Health
Australia signs agreement for new Covid-19 drug – Pharmaceutical Business Review
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths…
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths and hospitalisations due to Covid-19.
Being trialled in the US, this drug is yet to gain approval from the regulatory authorities.
…
-
Noosa News18 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General23 hours agoNew Spirit of Tasmania ferry arrives in Hobart, but will not be operating for more than a year
-
Noosa News23 hours agoScientists move precious ReefHQ coral ahead of Great Barrier Reef Aquarium build
-
General20 hours agoKen Hinkley has called time at the Power, but he’s the ‘proudest coach the world has seen’